HA-1–targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F. Krakow, Marie Bleakley, Robson G. Dossa et al.|Blood|2024Cited by 29
Decreasing chronic graft-versus-host disease rates in all populationsPaul A. Carpenter, Stephanie J. Lee, Julie R. Boiko et al.|Blood Advances|2024Cited by 23
Phase I Study of Adoptive Immunotherapy with HA-1-Specific CD8+ and CD4+ Memory T Cells for Children and Adults with Relapsed Acute Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation (HCT): Trial in ProgressElizabeth F. Krakow, Marie Bleakley, Corinne Summers et al.|Blood|2020Cited by 6
Post Hematopoietic Cell Transplantation Maintenance Therapy with Low-Dose Azacitidine in a Pediatric Population with High-Risk Myeloid NeoplasmsKatherine Tarlock, Ann Dahlberg, Todd M. Cooper et al.|Blood|2023Cited by 0
Post Hematopoietic Cell Transplantation Maintenance Therapy With Low-Dose Azacitidine in a Pediatric Population With High-Risk Myeloid MalignanciesEmily Merkel, Ann Dahlberg, Ted Gooley et al.|Transplantation and Cellular Therapy|2025Cited by 0